Vaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines

  • Investing.com
  • Stock Market News
Vaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines

Shares of Moderna (NASDAQ: MRNA ) and other vaccine stocks rose on Wednesday after Australia reported its first human case of avian influenza.

Moderna gained 13.7%, Pfizer (NYSE: PFE ) rose 3.6%, BioNTech SE (NASDAQ: BNTX ) jumped 11% and CureVac N.V. (CVAC) rallied 18%.

In a note to clients following the news, analysts at UBS said, "mRNA vaccines offer unprecedented speed/capabilities."

They added that while few human cases are confirmed, they note that "very little is known about the potential for human transmission and [the] broader public health risk."

UBS also noted that a "top investor inbound has been on [the] size of [the] recent stock move."

Elsewhere, Bloomberg reported that Moderna and Pfizer are in talks with the US on H5N1 bird flu vaccines.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100